Diverse Gut Microbiome Linked to Heightened Stress Response

IMT News Desk
IMT News Desk
· 2 min read
A University of Vienna study states that diverse gut bacteria boost stress reactivity and cortisol levels.

A groundbreaking study from the University of Vienna has found that individuals with more diverse gut bacteria exhibit stronger hormonal and subjective stress reactivity during acute stress. Published in Neurobiology of Stress, the research challenges conventional views by suggesting that higher microbial diversity may support adaptive, resilient stress responses rather than dampening them.

The study involved 74 healthy adults split into a stress group undergoing the established Trier Social Stress Test (TSST) and a control group performing a neutral task. Researchers collected saliva samples to measure cortisol levels, assessed subjective stress perceptions via questionnaires, and analyzed stool samples for microbiome composition and short-chain fatty acid (SCFA) production capacity.

Key results showed that greater gut microbial alpha diversity correlated with elevated cortisol output and higher perceived stress in the stress group, but not in controls. Notably, microbiomes with higher inferred butyrate production capacity were tied to increased stress reactivity, while propionate production was linked to lower reactivity. Lead researcher Thomas Karner, a psychologist at the University of Vienna, explained: “A robust acute stress response enables flexible adaptation to challenges, and diverse gut bacteria along with certain metabolites appear to facilitate this.”

These findings illuminate the gut-brain axis’s role in stress regulation, with implications for managing anxiety, depression, and related disorders through microbiome modulation via diet, probiotics, or lifestyle changes. While causation remains to be proven in larger trials, the study underscores how gut health could optimize everyday stress resilience.

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk